CD160, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for anti-CD160, Mouse antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD160, Mouse
CloneREA669
Host SpeciesRecombinant Human
Reactive Speciesmouse
IsotypeIgG1
FormatPE-Vio 770 conjugate
Size30 µg in 1 mL
Concentration1:10
ApplicationsFlow cytometry
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCD160 Antibody, anti-mouse, PE-Vio® 770, REAfinity™. Clone REA669 recognizes the mouse CD160 antigen, which is also known as BY55. CD160 is a 27 kDa glycoprotein which is expressed at the cell surface as a tightly disulfide-linked multimer. It binds both classical and non-classical MHC class I molecules. CD160 is a ligand for HVEM (herpes virus entry mediator), which attenuates TCR-mediated signaling. Furthermore it enhances proliferation of activated CD8+ T cells and regulates NK cell activation. | Additional information: Clone REA669 displays negligible binding to Fc receptors.
Immunogenn/a
Other NamesBY55
Gene, Accession #Gene ID: 12478
Catalog #130-110-159
Price$167
Order / More InfoCD160, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesAnumanthan, A. et al. (1998) Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 161 (6): 2780-2790. | Tsujimura, K. et al. (2006) Characterization of murine CD160+ CD8+ T lymphocytes. Immunol. Lett. 106 (1): 48-56. | Cai, G. et al. (2009) The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229 (1): 244-258.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.